Trademark search for:

TME NORMALIZATION

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2021-07-06 — Application filed
2021-07-09 — Application filed
2021-09-15 — Application filed
2022-03-24 — Assigned to examiner
2022-03-27 — Final disposition recorded
2022-03-27 — Final disposition recorded
2022-03-27 — Final disposition recorded
2022-08-29 — Attorney/dom.rep.revoked and/or appointed
2022-08-29 — Teas change of correspondence received
2022-08-29 — Teas revoke/app/change addr of atty/dom rep received
2022-09-27 — Office action issued
2022-11-10 — Teas/email correspondence entered
2022-11-10 — Applicant/correspondence changes (non-responsive) entered
2022-11-10 — Assigned to lie
2022-11-10 — Correspondence received in law office
2023-10-14 — Final disposition recorded
2023-10-14 — Final disposition recorded
2023-10-14 — Final disposition recorded
2024-01-16 — Application filed
2024-01-16 — Application filed
2024-05-04 — Application abandoned
2024-05-04 — Application abandoned
2024-05-04 — Final status recorded

Owner Information

Immix Biopharma, Inc.
Los Angeles , CA

Correspondent

Sheila R. Gibson Aura IP Law
3217 Carson Street #294
Lakewood, CA 90712
United States

Filing Details

Filing Date:
2021-07-06

Status Date:
2024-05-04

Category:
Pharmaceuticals

Filing Year:
2021

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.